UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004914
Receipt number R000005563
Scientific Title Validity of Sputum Induction Method for the Diagnosis of Lung Cancer
Date of disclosure of the study information 2011/01/21
Last modified on 2015/02/03 12:51:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validity of Sputum Induction Method for the Diagnosis of Lung Cancer

Acronym

Sputum Induction in Patients with Lung Cancer

Scientific Title

Validity of Sputum Induction Method for the Diagnosis of Lung Cancer

Scientific Title:Acronym

Sputum Induction in Patients with Lung Cancer

Region

Japan


Condition

Condition

Patients with suspected lung cancer

Classification by specialty

Pneumology Hematology and clinical oncology Adult

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

We aimed to evaluate the efficacy of induced sputum obtained by inhalation of hypertonic saline for 15 minutes, for the diagnosis of lung cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Sputum expectoration rate

Key secondary outcomes

1. Cytological examination of sputum induced by 10% hypertonic saline
2. Analysis of adverse events arising from the inhalation of 10% hypertonic saline
3. Testing of the lung carcinoma cells for EGFR gene mutation in sputum cytology-positive cases and comparison of the test results between spontaneous and induced sputum specimens
4. Questionnaire survey of the patients.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

Spontaneous sputum cytology specimens were collected from each subject for 3 days after registration. On each day during the subsequent 3-day period, each subject was asked to inhale nebulized 10% hypertonic saline (mixed with 0.5 mL salbutamol), in an attempt to induce sputum. Immediately before each session of sputum induction, the oral cavity was cleared of food residues and mucus. During the 15-minute saline inhalation, sputum was collected in a sterile dish. Three slides were prepared from each sputum sample, fixed in 95% ethanol, and stained with Papanicolaou method. After completion of the protocol, all patients fulfilled a questionnaire containing 4 questions on the induction procedures.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with suspected lung cancer based on the detection of an abnormal opacity on the chest X-ray. Written informed consent

Key exclusion criteria

(1) patients with uncontrolled asthma, (2) patients with severe hepatopathy, nephropathy, cardiac disease or hematological disease, or other serious complications, (3) pregnant or possibly pregnant women, and (4) other patients judged by the physician as being unsuitable candidates for the study.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuka Fujita

Organization

National Hospital Organization Asahikawa Medical Center

Division name

Clinical Reseach

Zip code


Address

7 Hanasaki-cho Asahikawa Hokkaido 070-8644 Japan

TEL

0166-51-3161

Email

yuka-1@hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuka Fujita

Organization

National Hospital Organization Asahikawa Medical Center

Division name

Respiratory Medicine

Zip code


Address

7 Hanasaki-cho Asahikawa Hokkaido 070-8644 Japan

TEL

0166-51-3161

Homepage URL


Email

yuka@asahikawamc.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Asahikawa Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構旭川医療センター


Other administrative information

Date of disclosure of the study information

2011 Year 01 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2009 Year 03 Month 25 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date

2013 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 01 Month 20 Day

Last modified on

2015 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005563


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name